UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Metabolomic profiling of asthma and chronic obstructive pulmonary disease: A pilot study differentiating diseases

Journal of allergy and clinical immunology, 2015-09, Vol.136 (3), p.571-580.e3

2015

Volltextzugriff (PDF)

A survey of severe asthma in Canada: results from the CASCADE practice reflective program

Allergy, asthma, and clinical immunology, 2024-04, Vol.20 (1), p.31-31, Article 31

2024

Volltextzugriff (PDF)

SARS-CoV-2-Induced TSLP Is Associated with Duration of Hospital Stay in COVID-19 Patients

Viruses, 2023-02, Vol.15 (2), p.556

2023

Volltextzugriff (PDF)

Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: a Canadian Thoracic Society clinical practice guideline

Canadian respiratory journal, 2011, Vol.18 (2), p.69-78

2011

Volltextzugriff (PDF)

Understanding facilitators and barriers to oxygen therapy for patients with interstitial lung disease

BMJ open respiratory research, 2024-09, Vol.11 (1), p.e002339

2024

Volltextzugriff (PDF)

Asthma-related emergency admissions and associated healthcare resource use in Alberta, Canada

BMJ open respiratory research, 2023-10, Vol.10 (1), p.e001934

2023

Volltextzugriff (PDF)

Increased Protease-Activated Receptor-2 (PAR-2) Expression on CD14++CD16+ Peripheral Blood Monocytes of Patients with Severe Asthma

PloS one, 2015-12, Vol.10 (12), p.e0144500-e0144500

2015

Volltextzugriff (PDF)

POWER: Prospective Cohort Study for the Real-Life Effectiveness Evaluation of Glycopyrronium With Indacaterol Combination in the Management of COPD in Canada

Chest, 2016-10, Vol.150 (4), p.835A-835A

2016

Volltextzugriff (PDF)

Stability of peripheral blood immune markers in patients with asthma

Allergy, asthma, and clinical immunology, 2019-04, Vol.15 (1), p.30-30, Article 30

2019

Volltextzugriff (PDF)

Distribution of Nitric Oxide Synthase in Normal and Cirrhotic Human Liver

Proceedings of the National Academy of Sciences - PNAS, 2002-12, Vol.99 (26), p.17161-17166

2002

Volltextzugriff (PDF)

Sleep laboratory test referrals in Canada: sleep apnea rapid response survey

Canadian respiratory journal, 2014-01, Vol.21 (1), p.e4-10

2014

Volltextzugriff (PDF)

Considerations in establishing bioequivalence of inhaled compounds

Expert opinion on drug delivery, 2018-02, Vol.15 (2), p.153-162

2018

Volltextzugriff (PDF)

Regulatory Approaches and Considerations in Establishing Bioequivalence of Inhaled Compounds

Journal of aerosol medicine and pulmonary drug delivery, 2018-02, Vol.31 (1), p.18-24

2018

Volltextzugriff (PDF)

Reevaluation of Diagnosis in Adults With Physician-Diagnosed Asthma

JAMA : the journal of the American Medical Association, 2017-01, Vol.317 (3), p.269

2017

Volltextzugriff (PDF)

THE TIME COST TO INVESTIGATE PULMONARY EMBOLISM IN COPD PATIENTS IN THE EMERGENCY ROOM

Chest, 2023-10, Vol.164 (4), p.A4883-A4884

2023

Volltextzugriff (PDF)

SHORT-ACTING BETA-AGONIST (SABA), ANTIBIOTICS, ORAL CORTICOSTEROID (OCS), AND RISK OF MORTALITY AND CARDIOPULMONARY EVENTS IN PATIENTS WITH COPD

Chest, 2023-10, Vol.164 (4), p.A4975-A4976

2023

Volltextzugriff (PDF)

Nitric oxide and cyclic GMP increase the expression of matrix metalloproteinase-9 in vascular smooth muscle

The Journal of pharmacology and experimental therapeutics, 2003-10, Vol.307 (1), p.429-436

2003

Volltextzugriff (PDF)

Introduction to the Canadian Scientific Advisory Committee on Respiratory and Allergy Therapies: in vivo evaluation for clinical testing in COPD and asthma therapy using generics

Journal of aerosol medicine and pulmonary drug delivery, 2012-08, Vol.25 (4), p.204-208

Mayers, Irvin

2012

Volltextzugriff (PDF)

Cost-effectiveness of combination therapy for chronic obstructive pulmonary disease

Canadian respiratory journal, 2008, Vol.15 (8), p.437-443

2008

Volltextzugriff (PDF)

The Transcription Factor Wilms Tumor 1 Regulates Matrix Metalloproteinase-9 through a Nitric Oxide-Mediated Pathway

Journal of Immunology, 2007-07, Vol.179 (1), p.256-265

2007

Volltextzugriff (PDF)

Early Diagnosis and Treatment of COPD and Asthma - A Randomized, Controlled Trial

The New England journal of medicine, 2024-06, Vol.390 (22), p.2061

2024

Volltextzugriff (PDF)

Climate change, Kyoto and the Canadian Thoracic Society

Canadian respiratory journal, 2002-07, Vol.9 (4), p.231-234

Mayers, Irvin

2002

Volltextzugriff (PDF)

A year of changes--a new year of opportunities

Canadian respiratory journal, 2002-01, Vol.9 (1), p.19, 21-21

Mayers, Irvin

2002

Volltextzugriff (PDF)

Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthma

The European respiratory journal, 2023-03, Vol.61 (3), p.2201193

2023

Volltextzugriff (PDF)

1 – 25 von 99

Suche als RSS-Feed

Aktive Filter

ThemaMedical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(92)
Mit Volltextzugriff
(81)

Publikationsform

Artikel
(97)
Buchkapitel
(2)

Sprache

Englisch
(99)

Erscheinungsjahr

n.n

Thema

Science & Technology
(57)
Life Sciences & Biomedicine
(55)
Humans
(46)
Respiratory System
(28)
Asthma
(25)
Male
(21)
Female
(20)
Adult
(17)
Middle Aged
(17)
Chronic Obstructive Pulmonary Disease
(15)
General & Internal Medicine
(15)
Aged
(14)
Copd
(13)
Canada
(11)
Patients
(10)
Asthma - Drug Therapy
(9)
Immunology
(9)
Inflammation
(9)
Medicine, General & Internal
(8)
Pulmonary Disease, Chronic Obstructive - Drug Therapy
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Metabolomic profiling of asthma and chronic obstructive pulmonary disease: A pilot study differentiating diseases

A survey of severe asthma in Canada: results from the CASCADE practice reflective program

SARS-CoV-2-Induced TSLP Is Associated with Duration of Hospital Stay in COVID-19 Patients

Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: a Canadian Thoracic Society clinical practice guideline

Understanding facilitators and barriers to oxygen therapy for patients with interstitial lung disease

Asthma-related emergency admissions and associated healthcare resource use in Alberta, Canada

Increased Protease-Activated Receptor-2 (PAR-2) Expression on CD14++CD16+ Peripheral Blood Monocytes of Patients with Severe Asthma

POWER: Prospective Cohort Study for the Real-Life Effectiveness Evaluation of Glycopyrronium With Indacaterol Combination in the Management of COPD in Canada

Stability of peripheral blood immune markers in patients with asthma

Distribution of Nitric Oxide Synthase in Normal and Cirrhotic Human Liver

Sleep laboratory test referrals in Canada: sleep apnea rapid response survey

Considerations in establishing bioequivalence of inhaled compounds

Regulatory Approaches and Considerations in Establishing Bioequivalence of Inhaled Compounds

Reevaluation of Diagnosis in Adults With Physician-Diagnosed Asthma

THE TIME COST TO INVESTIGATE PULMONARY EMBOLISM IN COPD PATIENTS IN THE EMERGENCY ROOM

SHORT-ACTING BETA-AGONIST (SABA), ANTIBIOTICS, ORAL CORTICOSTEROID (OCS), AND RISK OF MORTALITY AND CARDIOPULMONARY EVENTS IN PATIENTS WITH COPD

Nitric oxide and cyclic GMP increase the expression of matrix metalloproteinase-9 in vascular smooth muscle

Introduction to the Canadian Scientific Advisory Committee on Respiratory and Allergy Therapies: in vivo evaluation for clinical testing in COPD and asthma therapy using generics

Cost-effectiveness of combination therapy for chronic obstructive pulmonary disease

The Transcription Factor Wilms Tumor 1 Regulates Matrix Metalloproteinase-9 through a Nitric Oxide-Mediated Pathway

Early Diagnosis and Treatment of COPD and Asthma - A Randomized, Controlled Trial

Climate change, Kyoto and the Canadian Thoracic Society

A year of changes--a new year of opportunities

Efficacy and safety of multiple doses of QGE031 (ligelizumab) versus omalizumab and placebo in inhibiting allergen-induced early asthmatic responses

Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthma

Aktive Filter

Suchergebnisse filtern